title: Triplet pregnancy after ovulation induction with an aromatase inhibitor.
abstract: OBJECTIVE
  To describe the first reported case of a triplet pregnancy subsequent to the use of an aromatase inhibitor for ovulation induction.
  
  
  METHODS
  Case report.
  
  
  METHODS
  Academic medical center.
  
  
  METHODS
  A 32-year-old female with polycystic ovary syndrome and primary infertility.
  
  
  METHODS
  Letrozole, 5 mg/day, on cycle days 2 to 6 for ovulation induction.
  
  
  METHODS
  Clinical pregnancy.
  
  
  RESULTS
  Viable triplet gestation.
  
  
  CONCLUSIONS
  Use of an aromatase inhibitor for ovulation induction does not eliminate the risk for higher order multiple pregnancy.
authors.affiliation: Department of Obstetrics and Gynecology, Center for Women's Reproductive Care, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
authors.forename: Cary L
authors.initials: CL
authors.lastname: Dicken
authors.forename: Gary S
authors.initials: GS
authors.lastname: Nakhuda
authors.forename: Michael M
authors.initials: MM
authors.lastname: Guarnaccia
authors.forename: Mark V
authors.initials: MV
authors.lastname: Sauer
authors.forename: Rogerio A
authors.initials: RA
authors.lastname: Lobo
mesh_terms: D000328:Adult; D047072:Aromatase Inhibitors / Q000627:therapeutic use*; D005260:Female; D005300:Fertility Agents, Female / Q000008:administration & dosage*; D006801:Humans; D007247:Infertility, Female / Q000188:drug therapy*; D010062:Ovulation Induction / Q000379:methods*; D011247:Pregnancy; D016896:Treatment Outcome; D014310:Triplets
chemical_list: D047072:Aromatase Inhibitors; D005300:Fertility Agents, Female